[{"id":"0d51a3ad-8be1-4d5c-b868-0529a1a899f2","acronym":"","url":"https://clinicaltrials.gov/study/NCT00003736","created_at":"2021-01-17T22:52:53.866Z","updated_at":"2024-07-02T16:36:55.294Z","phase":"","brief_title":"MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer","source_id_and_acronym":"NCT00003736","lead_sponsor":"Abramson Cancer Center of the University of Pennsylvania","biomarkers":" BRCA1 • BRCA2","pipe":" | ","alterations":" BRCA2 mutation • BRCA1 mutation","tags":["BRCA1 • BRCA2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA2 mutation • BRCA1 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Xcytrin (motexafin gadolinum)"],"overall_status":"Completed","enrollment":" Enrollment 200","initiation":"Initiation: 06/01/1999","start_date":" 06/01/1999","primary_txt":" Primary completion: 06/01/2002","primary_completion_date":" 06/01/2002","study_txt":" Completion: 06/01/2002","study_completion_date":" 06/01/2002","last_update_posted":"2019-09-24"}]